Home > Newsletters > FDAnews Drug Daily Bulletin > Big Pharma Calls on Industry to Share Trial Results, End Ghostwriting
FDAnews Drug Daily Bulletin
May 30, 2012 | Vol. 9 No. 106
Big Pharma Calls on Industry to Share Trial Results, End Ghostwriting
Eight major pharmaceutical companies are calling on drugmakers to publicize all clinical trial results — including unfavorable results — to address a “credibility gap” for industry-sponsored research. Sponsors should also provide access to more complete protocol information for studies and report the statistical methods used in analyses, according to new recommendations from the pharma companies and several medical journals.
Clinical Trials Advisor
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.